COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leader in stem cell therapeutics, announced today that it will report its financial results for the quarter ended September 30, 2008, on Tuesday, November 4, 2008. C. Randal Mills, Ph.D., President and Chief Executive Officer, and Richard Hunt, Chief Financial Officer, will provide a company update and discuss results via a webcast and conference call on Tuesday, November 4, 2008 at 9:00 a.m. ET.
